IL37 and obesity disorder: The analysis of classical atherosclerotic risk factors revealed that the OR for the serum level of IL-23 > 3.1 pg/mL in SLE patients with obesity was 3.88 (95% CI 1.30–11.58), P = 0.015 (P = 0.015 after Bonferroni correction) (Table 7).